It has been widely described that immune activation, such as that induced by bacterial endotoxin (lipopolysaccharide, LPS) or by interleukin-1b (IL-1b) causes deficits in learning and memory. These studies have been performed in a limited number of paradigms and have often failed in their experimental design to account for features of sickness behaviour and have thus introduced potential confounding factors. As such, this literature provides an oversimplified view of the issues. A detailed reading of the literature reveals that rodents treated with LPS or IL-1b, whether systemically or centrally, do not reproducibly show clear impairments in spatial reference memory in the Morris Water Maze. Latency to find the platform is almost invariably increased, consistent with sickness and reduced locomotor speed in these animals. In studies where distance travelled or route to the platform have been examined there have been either very modest or no differences between treated groups, or stress-induced, thigmotaxic, strategies employed by the sick animals. This suggests that emotional and performance changes are more significant than cognitive impairments. There is better evidence for a deficit in contextual fear conditioning experiments induced by LPS and IL-1b and these effects are clearly dose-dependent, with facilitation at low doses and impairment at higher doses. We propose that the field should be more cautious and more specific in its description of these cognitive effects and that new tasks be employed in these studies, that are not susceptible to confounding factors such as locomotor speed and elevated stress responses. Emerging data suggests that systemic insults induce more robust memory impairments in aged rodents or those with pre-exisiting neurodegenerative disease and these effects are consistent with the mild effects of infection on cognitive processes in young or healthy adults and the more severe effects, such as delirium, in the elderly and demented population.
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Introduction
''What happens to the rat that finally stops running the maze ? The doctors think he's dumb, when he's just disappointed" Mark Eitzel, American Music Club
The concept that sickness behaviour has evolved as a coordinated set of behaviours driven by specific brain centres to conserve energy, support the fight against infection and mimimise spread of infection is now widely accepted. Since the demonstration that systemic events can alter CNS function many other CNS effects have been ascribed to this periphery-to-brain communication. Among these is the idea that systemic LPS, and/or proinflammatory cytokines have a deleterious effect on memory and learning. Though there are relatively few papers on this subject, employing few experimental paradigms, the idea that systemic inflammation impairs memory and learning appears to have become dogma in the psychoneuroimmunology field. However, in many cases the studies on which this reasoning is founded have failed to take account of the effects of LPS on stress, motivation, locomotor activity and speed of movement. All of these parameters are acutely impaired by LPS treatment (and to a lesser degree by IL-1b) and gradually recover over a period of approximately 24 h. The effect of LPS on these parameters can confound tests of learning and memory. While it is undoubtedly true that LPS and IL-1b have deleterious effects in some paradigms, they are not necessarily amnesic effects. In this review, we will make a critical assessment of the current literature on the effects of infection, LPS and pro-inflammatory cytokines on learning and memory in rodents.
Early experiments
Most of what we know about immune stimulation and cognitive processes comes from studies in rodents. The first clear indica- 
